We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Geistlich Bio-Oss®

Geistlich Bio-Oss® is the leading natural bone substitute in regenerative dentistry worldwide1,2. The outstanding osteo-conductive properties of Geistlich Bio-Oss® lead to effective and predictable bone regeneration3-5. Geistlich Bio-Oss® particles become an integral part of the newly formed bone framework and preserve volume over the long term6-9. Subsequent application of a Geistlich Bio-Gide® collagen membrane enables undisturbed regeneration in the augmented area10.


Leading clinicians rely on Geistlich Bio-Oss® because:

  • Geistlich Bio-Oss® augmented bone leads to high implant survival rates, comparable with implants placed in pristine bone4,5.
  • Geistlich Bio-Oss® is easy to apply and can be used in the most varied indications.
  • Geistlich Bio-Oss® is validated by over 30 years of successful use and testing, documented in more than 1000 scientific publications.
“Geistlich products have earned my trust over the years.”
Prof. Mariano Sanz, Madrid, Spain

In the 1980s, Dr. Peter Geistlich was the first to remove organic components from bone material without changing the natural microstructure and bone composition. Nowadays, Geistlich Bio-Oss® is regarded as the state-of-the-art bone substitute in dental bone regeneration – meeting the requirement from clinicians for predictable outcomes.



  1.  Millennium Research Group, Dental Biomaterials North America, 2018 (Market research).
  2.  Millennium Research Group, Dental Biomaterials Europe, 2018 (Market research).
  3.  Orsini G et al.,Oral Dis. 2007, Nov;13(6):586–93 (Clinical study).
  4.  Jung R et al., Clin Oral Implants Res. 2013 Oct;24(10):1065–73 (Clinical study).
  5.  Aghaloo TL et al., Int J Oral Maxillofac Implants. 2007; 22(suppl):49–70 (Clinical study).
  6.  Maiorana C et al., Int J Periodontics Restorative Dent. 2005 Feb;25(1):19–25.(Clinical study)
  7.  Traini T et al., J Periodontol. 2007 May; 78(5):955–61 (Clinical study).
  8.  Mordenfeld A et al., Clin. Oral Implant Res. 2010, Sep;21(9):961–70 (Clinical study).
  9.  Galindo-Moreno P et al., Clin Implant Dent Relat Res. 2013 Dec;15(6):858-66 (Clinical Study).
  10.  Perelman-Karmon M et al., Int J Periodontics Restorative Dent.2012 Aug;32(4):459–65 (Clinical study).


Verena Vermeulen
Group Lead Clinical Marketing